ELVN
Enliven Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$59.43
−0.36%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.15x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 1.27x
Liquidity & coverage
- Current ratio
- 64.07x
- Quick ratio
- 64.07x
- Cash ratio
- 63.21x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $893.2M
Cash & dividend
- FCF / debt
- -44.40x
- Cash flow / debt
- -44.33x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026